HIV-1-specific CD4+ responses in primary HIV-1 infection predict disease progression

AIDS

Volumn 28, Issue 5, 2014, Pages 699-708

  Frater, John ^a,b,c,d   Ewings, Fiona ^e,f,g   Hurst, Jacob ^a,b,c,d   Brown, Helen ^a,b,c,d   Robinson, Nicola ^a,b,c,d   Fidler, Sarah ^h   Babiker, Abdel ^e   Weber, Jonathan ^h   Porter, Kholoud ^e   Phillips, Rodney E ^a,b,c,d  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g Division of Medicine Wright Fleming Institute Imperial College ^*

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cell mediated immunity; Clinical; ELISPOT; Primary HIV infection; Progression

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SURVIVAL; VIRUS LOAD; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PROGNOSIS; SECRETION (PROCESS); VIROLOGY;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; MALE; PROGNOSIS;

EID: 84898726122     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000130     Document Type: Article

References (29)

1. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68: 4650-4655.
2. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virusspecific CD8+cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994; 68: 6103-6110.
3. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283: 857-860.
4. O'Brien SJ, Gao X, Carrington M. HLA and AIDS: a cautionary tale. Trends Mol Med 2001; 7: 379-381.
5. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317: 944-947.
6. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13: 46-53.
7. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003; 77: 2081-2092.
8. Asquith B, Edwards CT, Lipsitch M, McLean AR. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol 2006; 4: e90.
9. Sant AJ, McMichael A. Revealing the role of CD4+ T cells in viral immunity. J Exp Med 2012; 209: 1391-1395.
10. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997; 278: 1447-1450.
11. Ranasinghe S, Flanders M, Cutler S, Soghoian DZ, Ghebremichael M, Davis I, et al. HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome. J Virol 2012; 86: 277-283.
12. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Okamoto Y, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002; 417: 95-98.
13. Chevalier MF, Jülg B, Pyo A, Flanders M, Ranasinghe S, Soghoian DZ, et al. HIV-1-specific interleukin-21R CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J Virol 2011; 85: 733-741.
14. Norris PJ, Moffett HF, Yang OO, Kaufmann DE. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4+ T cells. J Virol 2004; 78: 8844-8851.
15. Appay V. The physiological role of cytotoxic CD4+ T-cells: the holy grail? Clin Exp Immunol 2004; 138: 10-13.
16. Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, et al. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med 2012; 4: 123.
17. Fidler S, Porter K, Ewings F, Frater J, Ramjee G, Cooper D, et al. Short-course antiretroviral therapy in primary HIV infection. New Engl J Med 2013; 368: 207-217.
18. Fidler S, Oxenius A, Brady M, Clarke J, Cropley I. Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection. AIDS 2002; 16: 2049-2054.
19. Mlotshwa M, Riou C, Chopera D, de Assis Rosa D, Ntale R, Treunicht F, et al. Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression. J Virol 2010; 84: 12018-12029.
20. Altfeld M, Kalife ET, Qi Y, Streeck H, Lichterfeld M, Johnston MN, et al. HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(R) T cell response against HIV-1. PLoS Med 2006; 3: 1851-1864.
21. Prendergast A, Goodliffe H, Clapson M, Cross R. Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection. AIDS 2011; 10: 1329-1331.
22. Buggert M, Norström MM, Czarnecki C, Tupin E, Luo M. Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage. PLoS ONE 2012; 7: e39874.
23. Streeck H, D'Souza MP, Littman DR, Crotty S. Harnessing CD4(R) T cell responses in HIV vaccine development. Nat Med 2013; 19: 143-149.
24. Lindqvist M, van Lunzen J, Soghoian DZ, Kuhl BD, Ranasinghe S, Kranias G, et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 2012; 122: 3271-3280.
25. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107: 4781-4789.
26. Cossarizza A, Bertoncelli L, Nemes E, Lugli E, Pinti M, Nasi M, et al. T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. PLoS ONE 2012; 7: e50728.
27. Turk G, Ghiglione Y, Falivene J, Socias ME, Laufer N, Coloccini RS, et al. Early Gag immunodominance of the HIV-specific Tcell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment. J Virol 2013; 87: 7445-7462.
28. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomized, placebocontrolled, test-of-concept trial. Lancet 2008; 372: 1881-1893.
29. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361: 2209-2220.